Medicare Enrolled

Dr. Mitchell Haut, M.D.

Hematology & Oncology · Canton, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1455 HARRISON AVE NW, Canton, OH 44708
3304539993
In practice since 2005 (21 years)
NPI: 1023015674 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Haut from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haut? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Haut

Dr. Mitchell Haut is a hematology & oncology specialist in Canton, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Haut performed 506 Medicare services across 269 unique beneficiaries.

Between the years covered by Open Payments, Dr. Haut received a total of $5,821 from 54 pharmaceutical and/or device companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Haut is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ 506 Medicare services $5,821 industry payments

Medicare Practice Summary

Medicare Utilization ↗
506
Medicare services
Bottom 48% in OH for hematology & oncology
269
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~24 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
266 $102 $591
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
107 $23 $218
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $69 $419
New patient office visit, complex (60-74 min) 32 $135 $788
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $100 $1,060
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2022 ↗
$5,821
Total received (2018-2022)
Avg $1,164/year across 5 years
Top 36% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
356
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,544 (95.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$277 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2022
$25
2021
$689
2020
$788
2019
$2,279
2018
$2,041

Payments by company (2022)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$25
Top 3 companies account for 100.0% of 2022 payments
All-time payments by company (2018-2022) ›
E.R. Squibb & Sons, L.L.C.
$718
Novartis Pharmaceuticals Corporation
$461
Genentech USA, Inc.
$413
Celgene Corporation
$347
AstraZeneca Pharmaceuticals LP
$327
Merck Sharp & Dohme Corporation
$263
Amgen Inc.
$244
Janssen Biotech, Inc.
$213
Puma Biotechnology, Inc.
$186
GENZYME CORPORATION
$163
Clovis Oncology, Inc.
$150
PFIZER INC.
$130
Bayer HealthCare Pharmaceuticals Inc.
$128
Lilly USA, LLC
$123
TESARO, Inc.
$117
GlaxoSmithKline, LLC.
$113
EISAI INC.
$111
AMAG Pharmaceuticals, Inc.
$110
Eisai Inc.
$105
Exelixis Inc.
$90
Lexicon Pharmaceuticals, Inc.
$86
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
Partner Therapeutics, Inc.
$78
Ipsen Biopharmaceuticals, Inc
$73
Seagen Inc.
$68
Pharmacyclics LLC, An AbbVie Company
$66
Regeneron Healthcare Solutions, Inc.
$65
Incyte Corporation
$64
Teva Pharmaceuticals USA, Inc.
$63
BeiGene USA, Inc.
$62
Astellas Pharma US Inc
$59
EMD Serono, Inc.
$46
Dendreon Pharmaceuticals LLC
$44
Seattle Genetics, Inc.
$44
Takeda Pharmaceuticals U.S.A., Inc.
$43
Helsinn Therapeutics (U.S.), Inc.
$40
PUMA BIOTECHNOLOGY, INC.
$37
Agios Pharmaceuticals, Inc.
$36
Heron Therapeutics, Inc.
$27
Foundation Medicine, Inc.
$22
Secura Bio, Inc.
$21
INSYS Therapeutics Inc
$20
Alexion Pharmaceuticals, Inc.
$19
Advanced Accelerator Applications
$17
ARRAY BIOPHARMA INC
$15
Acceleron Pharma, Inc.
$14
Aveo Pharmaceuticals, Inc.
$14
Janssen Pharmaceuticals, Inc
$14
Gilead Sciences, Inc.
$13
Rigel Pharmaceuticals, Inc.
$12
Shionogi Inc
$12
Kite Pharma, Inc.
$12
JAZZ PHARMACEUTICALS INC.
$12
MEDIVATION FIELD SOLUTIONS LLC
$11
Top 3 companies account for 27.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · Abraxane · Alecensa · Avastin · BENDEKA · BESPONSA · BLENREP · BRUKINSA · Bavencio · CALQUENCE · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELITEK · FARYDAK · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · GILOTRIF · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · Leukine · Lutathera · MEKINIST · MEKTOVI · MONJUVI · MVASI · MYLOTARG · Mulpleta · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OPDIVO · PADCEV · PIQRAY · PROMACTA · PROVENGE · Perjeta · Pomalyst · REBLOZYL · RYDAPT · Reblozyl · Revlimid · Rubraca · SANDOSTATIN LAR · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TAFINLAR · TAGRISSO · TAXOTERE · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · VENCLEXTA · VERZENIO · VOTRIENT · XALKORI · XARELTO · XOSPATA · XTANDI · Xermelo · Xofigo · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Canton?
Compare hematology & oncology specialists in the Canton area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
31
Per 100K population
8.3
County median income
$65,740
Nearest hospital
MERCY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2022
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Haut is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Haut experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Haut performed 266 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haut receive payments from pharmaceutical companies?
Yes. Dr. Haut received a total of $5,821 from 54 companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haut's costs compare to other hematology & oncology specialists in Canton?
Dr. Haut's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haut) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →